RE:RE:RE:RE:RE:RE:RE:EarningsOur Q4 numbers were higher than 5.58 million lol this would suggest a sales decline after a full 3 months of sales from phase II (which has tripled our capacity). We signed a few wholesale deals this quarter and invested in clinics to register patients. Any inventory surplus they will sell to other LP's who are at capacity, thats a no brainer. Like I said in my last post.. 7.8 - 8.4 million revenue IMO.
Always better for analysts to aim low, shoot high. Look what happened to Air Canada's stock just the other day.
stupedaso wrote: The consensus for Q1 seems to be 5.58m with a high of 5.8m
I think over 6m is doable for sure.
Again only a couple weeks or so for Phase 2 sales, though i'm thinking it wont be a problem to hit 6m+
I see estimates of FY 2018 to be at $0.05, so far.
We might even hit that Q1 let alone the whole year.
Info gathered from
APH Tearsheet Mike411Ontario wrote:
Hello Numbers99, if I may join in his absence. Guess based on last qtr.
Additional production coming from Phase 2 for this coming earnings report.
Lots of sunshine great weather, any early estimates? Blue is it to early ,
Return on investments * these guys are good.
Good Management tends to outperm.
Last Qtr Q4 looked like this;
Revenue (000’s) $ 5,717.9
Kilograms sold 738.3
CCash cost to produce / gram (Aphria’s definition) $1.11
AAdjusted gross margin 86%
( $ 5,118.5 Revenue compared to the previous qtr 11.7% increace.
738.3 Kilograms sold compared to 652.7 the previous 13% increace.
Any early estimates knowledgeable guesses? $6.3 rev & 835 kg sold uses the #s above.